Modem evaluation of the hypertensive patient: Autonomie tone in cardiovascular disease and the assessment of heart rate variability

Blood Pressure Monitoring

Volumn 4, Issue SUPPL. 1, 1999, Pages

  Kerut, Edmund K ^a   McKinnie, James J ^a   Giles, Thomas D ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Autonomie tone; Cardiovascular disease; Heart rate variability

Indexed keywords

AMIODARONE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FLECAINIDE; PROPRANOLOL; SCOPOLAMINE;

AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; CHOLINERGIC SYSTEM; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; ELECTROCARDIOGRAM; HEART FAILURE; HEART INFARCTION; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MATHEMATICS; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SIGNAL PROCESSING; SUDDEN DEATH; SYMPATHETIC TONE;

HEART RATE; HUMANS; HYPERTENSION; PREDICTIVE VALUE OF TESTS;

EID: 0033497083     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Hales S. Statical Essays, vol. II. Haemostaticks. London: Innings & Manby & Woodward; 1733.
2. On Z, Monir G, Weiss J, Sayhoune X, Singer DH. Heart rale variability. Frequency domain analysis. Cardiol Clin 1992; 10:499-533.
3. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93:1043-1065.
4. Julius S, Randall OS. Role of the autonomie nervous system in mild human hypertension. Clin Sei Mol Med 1975; 48:2433-2523.
5. Korner PI, Shaw J, Uther JB, West MJ, McRitchie RJ, Richards JG, et al. Autonomie and non-autonomie circulatory components in essential hypertension in man. Circulation 1973; 48:107-117.
6. Liao D, Cai J, Barnes RW, Tyroler HA, Rautaharju P, Holme I, ef aJ. Association of cardiac autonomie function and the development of hypertension. Am J Hypertens 1996; 9:1147-1156.
7. Casolo G, Balli E, Taddei T, Amuhasi J, Gori C. Decreased spontaneous heart rate variability on congestive heart failure. Am J Cardiol 1989; 64:1162-1167.
8. Saul JP, Arai Y, Berger R D, Lily LS, Wilson S, Colucci WS, er al. Assessment of autonomie regulation in chronic congestive heart failure by the heart rate spectral analysis. Am J Cardiol 1988; 61:1292-1299.
9. Binkley PF, Nunziata E, Haas GJ, Nelson SO, Cody RJ. Parasympathetic withdrawal is an integral component of autonomie imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 1991 ; 18:464-472.
10. Liao D, Cai J, Barnes RW, Tyroler HA, Rautaharju P, Holme I, Heiss G. Association of cardiac autonomie function and the development of hypertension. The ARIC Study. Am J Hypertens 1996; 9:1147-1156.
11. Singh JP, Larson MG, Tsuji H, Evans JC, O'Donnell CJ, Levy D. Reduced heart rate variability and new onset hypertension: Insights into pathogenesis of hypertension. Hypertension 1998; 32:293-297.
12. Abboud S, Barnea O. Errors due to sampling frequency of the electrocardiogram in spectral analysis of heart rate signals with low variability. IEEE Comp Cardiol 1995; 461-463.
13. Merri M, Farden DC, Mottley JG, Titlebaum EL Sampling frequency of the electrocardiogram for spectral analysis of the heart rate variability. IEEE Trans Biomed Eng 1990; 37:99-106.
14. Nygrads ME, Sornms L Delineation of the QRS complex using the envelope of the ECGO. Med Biol Eng Comput 1983; 21:538-547
15. Thaker NV, Webster JG, Tompkins WJ. Optimal QRS detector. Med Biol Eng Compuf\ 983; 21:343-350.
16. Berger RD, Akselrod S, Gordon D, Cohen RJ. An efficient algorithm for spectral analysis of the heart rate variability. IEEE Trans Biomed Eng 1986; 33:900.
17. Ramanathan A, Chungath JJ, Myers GA. Stationarity constraints on heart rate variability data reduce spectral variance, improving reliability of estimated spectra. IEEE Comp Cardiol 1993; 2:738-739.
18. Lewis CD. Statistical monitoring techniques. Med Biol Eng Comput 1971; 9:315-323.
19. Ramanathan A, Kienzle MG, Myers GA. Preprocessing heart rate variability data improves risk stratification in congestive heart failure. IEEE Comp Ca/tf/o/1996; 29-31.
20. Krauss T. Beware of shortcomings when applying classical spectral-analysis techniques. Personal Engineering 1997; 36-42.
21. Welch PD. The use of fast Fourier transaform for the estimation of power spectra: a method based on time averaging over short, modified periodograms. IEEE Trans Audio Electroacoust 1967; 15:70-73.
22. Press WH, Teukolsky SA, Vetterling WT, Rannery BP. Numerical Recipes in Fortran: The Art of Scientific Computing, 2nd edn. New York: Cambridge University Press; 1992. pp 545-551.
23. Press WH, Teukolsky SA, Vetterling WT, Rannery B P. Numerical Recipes in Fortran: The Art of Scientific Computing, 2nd edn. New York: Cambridge University Press; 1992. pp 565-561.
24. Makhoul J. Linear prediction: a tutorial review. In Childers DG (editor): Modern Spectrum Analysis. New York: IEEE Press; 1978. pp. 99-118.
25. Wolf M, Varigos G, Hunt D, Sloman J. Sinus arrhythmia in acute myocardial infarction. Med J Aust 1978; 2:52-53.
26. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increase after acute myocardial infarction. Am J Card/o/ 1987; 59:256-262.
27. Bigger JT Jr, Reiss JL, Rolnitzky LM, Steinman RC. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992; 85:164-171.
28. Cox DR. Regression models and life tables (with discussion). J R Stat Soc Br 1972; 34:187-220.
29. Farrell TG, Bashir Y, Cripps T, Malik M, Poloniecki J, Bennett ED, et al. Risk stratification for arrhythmics events in post infarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal averaged electrocardiogram. J Am Coll Cardiol 1991; 18:687-697.
30. McAreavy D, Neilson JMM, Ewing DJ, Rüssel DC. Cardiac parasympathetic activity during the early hours of acute myocardial infarction. Br Heart J 1989; 62:165-170.
31. LaRovere MT, Speechia G, Mortara A, Schwartz PJ. Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction: a prospective study. Circulation 1998; 78:816-824.
32. Zuanetti G, Neilson JMM, Latin! R, Santoro E, Maggioni A, Ewing DJ, on behalf of GISSI-2 Investigators. Prognostic significance of heart rate variability in post myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Circulation 1996; 94:432-436.
33. Flapan AD, Wright RA, Nolan J, Neilson JM, Ewing DJ. Differing patterns of cardiac parasympathetic activity and their evolution in selected patients with a first myocardial infarction. J Am Coll Cardiol 1993; 21:926-931.
34. Bigger JT Jr, Reiss JL, Roinitzky LM, Steinman RC, Schneider WJ. Time course of recovery of heart period variability after myocardial infarction. J Am Coll Cardiol 1991; 18:1643-1649.
35. Malik M, Cripps T, Farrell T, Camm AJ. Prognostic value of heart rate variability after myocardial infarction. A comparison of different data processing methods. Med Biol Eng Comput 1989; 27:603-611.
36. LaRovere MT, Mortana A, Bigger JT, Marcus Fl, Camm AJ, Hohnloser SH, et al. The prognostic value of baroreflex sensitivity and heart rate variability after myocardial infarction. The ATRAMI Study. Circulation 1998; 94:1-19 (Abstr).
37. Lown B, Verrier RL Neural activity and ventricular fibrillation. W Engl J Med 1976; 294:1165-1170.
38. Schwartz PJ, LaRovere MT, Vanoli E. Autonomie nervous system and sudden cardiac death. Circulation 1992; 85 (suppl 1):77-97.
39. Schwartz PJ, Vanoli E, Stramba-Badiale M, De Ferrari GM, Billman GE, Foreman RD. Autonomie mechanisms and sudden death: new insights from the analysis of baroreceptor reflexes in conscious dogs with and without a myocardial Infarction. Circulation 1988; 78:969-979.
40. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular diseases. Circulation 1989; 79:733-743.
41. Farrell TG, Cripps TR, Malik M, Bennett ED, Ward D, Camm AJ. Baroreftex sensitivity and electrophysiological correlates in patients after acute myocardial infarction. Circulation 1991; 83:945-952.
42. Valkama JO, Huikuri HV, Koistinen MJ, Yli-Mayry S, Airaksinen KEJ, Myerburg RJ. Relation between heart rate variability and spontaneous and induced ventricular arrhythmias in patients with coronary artery disease. J Am Coll Cardiol 1995; 25:437-443.
43. Vybiral T, Classer DH, Goldberger Al, Rigney DR, Hess KR, Mietus J, et al. Heart rate variability analysis of ambulatory electrocardiographic recordings fails to predict imminent ventricular fibrillation. J Am Coll Cardiol 1993; 22:557-565.
44. Brembilla-Perrot B, Ross M, Jacquemin L, Beurrier D, Houplon P, Danchin N. Analysis of heart rate variability before and at the moment of cardiac death. Arch Mal Coeur 1997; 90:1477-84.
45. Saul JP, Arai Y, Berger RD, Lily LS, Wilson S, Colucci WS, Cohen RJ. Assessment of autonomie regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol 1998; 61:1292-1299.
46. Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ. Parasympathetic withdrawal is an integral component of autonomie imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Co/I Cardiol 1991; 18:464-472.
47. Fauchier L, Babuty D, Cosnay P, Autret ML, Fauchier JP. Heart rate variability in idiopathic dilated cardiomyopathy. Characteristics and prognostic value. J Am Coll Cardiol. 1997; 30:1009-10014.
48. Mortara A, Sleight P, Pinna GP, Maestri R, Prpa A, LaRovere MT, et al. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomie tone by measures of heart rate variability. Circulation 1997; 96:246-252.
49. Tsuji H, Venditti HJ, Manders ES, Evans JC, Larson MG, Feldman CL, ef al. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 1994; 90:878-83.
50. Dekker JM, Schouten EG, Klootwijk P, Swenne CA, Krunhout D. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am J Epidemiol 1997; 145:899-908.
51. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J. Heart rate variability from 24-hour electrocardiography and the 2-year risk of sudden death. Circulation 1993; 88:180-185
52. Kaufman ES, Bosner MS, Bigger JT Jr, Stein PK, Kleiger RE, Rolnitzky LM, et al. Effects of digoxin and enalapril on heart period variability. Response to head-up tilt in normal subjects. Am J Cardiol 1993; 72:95-99.
53. Krum H, Bigger JT Jr, Goldsmith RL, Packer M. Long-term therapy with digoxin reduces sympathetic and enhances parasympathetic nervous system activity in patients with chronic heart failure. Circulation 1993; 88:1108.
54. Wallin G. Intraneural recording and autonomie function in man. In Bannister R (editor): Autonomie Failure. London: Oxford University Press; 1983. pp. 3651.
55. Pagani M, Lombard! F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, ef aJ. Power spectral analysis of heart rate and arterial pressure variability is a marker of sympatho-vagal interactions in man and conscious dog. Circ Res 1986; 59:178-193.
56. Cook JR, Bigger JT, Kleiger RE, Reiss JL, Steinman RC, Rolnitzky LM. The effect of atenolol and diltiazem on heart period variability in normal persons. J Am Coll Cardiol 1991; 17:480-484.
57. Niemela MJ, Airaksinen KFJ, Huikuri H. Effect of beta-blockade on heart rate variability in patients with coronary artery disease. J Am Coll Cardiol 1994; 23:1370-1377.
58. Goldsmith RL, Krum H, Bigger JT Jr, et al. Beta-blockade increases parasympathetic activity in chronic heart failure. Circulation 1993; 88:1103.
59. Vybiral T, Bryg RJ, Maddens ME, Bhasin SS, Cronin S, Boden WE, Lehmann MH, et al. Effects of transdermal scopolomine on heart rate variability in normal subjects. Am J Cardiol 1990; 65:604-608.
60. Casadei B, Conway J, Meyer TE, Sleight P. Low doses of scopolomine increase cardiac vagal tone in the acute phase of myocardial infarction. Circulation 1993; 88:353-357.
61. Zuanetti G, Latini R, Neilson JMM. Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. J Am Coll Cardiol 1991; 17:604-612.
62. Fei LI. Effects of pharmacologie interventions on heart rate variability. In Malik M, Camm J (editors): Heart Rate Variability. Armonk, NY: Futura; 1995, pp. 275-291.